查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014683

胃腸內視鏡設備市場：按產品類型、可重複使用性、年齡層、應用和最終用戶分類－2026-2032年全球市場預測

Gastrointestinal Endoscopy Devices Market by Product Type, Reusability, Age Group, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年，胃腸內視鏡設備市值為160.7億美元，預計2026年將成長至169.7億美元，複合年成長率為5.96%，到2032年將達到241億美元。

主要市場統計數據
基準年 2025 160.7億美元
預計年份：2026年 169.7億美元
預測年份 2032 241億美元
複合年成長率 (%) 5.96%

全面概述了正在重新定義胃腸內視鏡設備優先事項的臨床需求、技術融合和採購趨勢。

胃腸內視鏡設備市場正處於臨床需求與快速技術進步的交匯點，創新重點在於提高診斷準確性、治療能力和病人安全性。依賴內視鏡可視化的各項操作貫穿從常規篩檢到複雜介入治療的廣泛臨床路徑。因此，參與臨床實踐、生產製造和醫療系統採購的相關人員都在優先考慮那些能夠縮短手術時間、降低併發症率並與數位化醫療工作流程無縫整合的設備。

對成像技術的突破、感染控制的優先性以及治療方法的擴展如何重塑競爭動態和產品藍圖。

近年來，在臨床需求與技術能力融合的驅動下，胃腸內視鏡生態系統中競爭優勢的重新定義正經歷變革性的加速。光學技術和高解析度成像技術的創新提升了診斷性能，而數位平台和人工智慧的融合則進一步增強了病灶檢出、手術記錄和術後分析。這些技術進步正在改變人們的預期，要求儀器製造商從產品設計的早期階段就考慮軟體整合、流程升級和互通性。

對美國 2025 年的新關稅措施將如何影響內視鏡設備產業相關人員的採購、購買行為和供應鏈韌性進行策略分析。

美國2025年實施的新關稅措施對內視鏡設備製造商和採購商產生了重大影響，波及採購、供應鏈設計和定價策略。由於關稅導致進口零件和成品成本增加，製造商正在重新評估其全球採購體系，審查供應商契約，並探索近岸外包方案以減輕進口關稅的影響。這些調整需要仔細評估總到岸成本、前置作業時間波動和供應商可靠性，尤其對於先進光學元件、照明系統和精密手術器械等特殊零件而言更是如此。

從詳細的細分觀點揭示產品類型、可重複使用性、患者人口統計特徵、應用和醫療保健環境如何指導差異化的策略選擇。

細分市場層面的趨勢揭示了各細分市場特有的機會和限制因素，這些對於產品策略、商業化和臨床應用都至關重要。按產品類型分類，市場涵蓋配件、內視鏡、手術器械和視覺化設備。配件進一步細分為攝影機、導管導引線和插入管；內視鏡細分為軟式內視鏡內視鏡和硬式內視鏡；手術器械細分為鑷子、剪刀和勒除器；可視化設備細分為攝影機、光源、顯示器和視訊處理器。這種產品類型的細分突顯了模組化和可升級性如何影響購買偏好：醫院傾向於選擇視覺化系統，而專科診所則傾向於選擇支援特定手術的最佳化配件組合。

跨區域分析揭示了臨床需求模式、監管多樣性和市場基礎設施​​如何塑造世界各地不同的採用路徑。

區域環境塑造了臨床需求、監管路徑和經營模式，進而影響短期部署模式和長期策略投資。在美洲，醫療服務體系呈現出大規模學術醫療中心、大規模的綜合醫療網路以及數量快速成長的門診機構並存的模式。這些因素共同催生了對擴充性平台的需求，這些平台需互通性，並提供強力的臨床證據以支持報銷。報銷框架和基於價值的採購舉措正日益影響採購流程，促使供應商提供可靠的衛生經濟學數據和服務模式，以降低總手術成本。

對公司層面的優勢進行權威評估，揭示技術廣度、臨床證據和全面的服務生態系統如何決定市場領導地位。

市場領導地位的形成源自於技術深度、與臨床機構的緊密合作以及全面的服務傳遞。領先的醫療設備製造商正投資於涵蓋光學系統、配件生態系統和整合式視覺化平台的端到端解決方案，以期在所有醫療環境中提供一致的治療體驗。醫療設備製造商與耗材供應商之間的策略合作，透過提供捆綁式服務包，降低了平台轉換的門檻，簡化了預算和維護流程，從而創造了具有競爭力的價值提案。

一系列切實可行且影響深遠的建議，旨在指導領導者協調產品架構、供應鏈彈性和臨床證據，從而建立永續的競爭優勢。

產業領導者必須果斷且靈活地將新興趨勢轉化為永續的競爭優勢。首先，他們必須投資於產品模組化和互通性，透過軟體升級和配件更新而非徹底更換硬體來發展其平台，從而保持客戶忠誠度並降低產品採用門檻。同時，他們必須擴展臨床證據項目，不僅要證明治療的有效性，還要證明其對後續醫療保健的益處。這些數據有助於鞏固他們在以價值主導的採購模式中的地位，並為有利的報銷談判提供支持。

本研究清楚地展示了一種混合方法的研究途徑，該方法結合了對臨床醫生的訪談、文獻整合和檢驗，並檢驗了技術和商業性見解。

本調查方法結合了第一手和第二手研究手段，以確保分析的嚴謹性和實際應用價值。第一手研究包括對臨床醫生、採購經理、臨床工程師和醫療設備製造商的高階主管進行結構化訪談，以揭示實際應用中的推廣促進因素、營運挑戰和採購慣例。除了這些直接洞察之外，還與監管和報銷專家進行了有針對性的諮詢，以了解不同司法管轄區的市場准入壁壘和促進因素。

一項權威的綜合分析揭示了為什麼臨床證據、強大的營運系統和有針對性的商業化相結合是胃腸內視鏡設備成功的關鍵。

總而言之，胃腸內視鏡設備的格局正在多種因素的共同作用下不斷演變，包括成像技術的進步、感染控制的需求以及內視鏡治療作用的日益增強。這些因素正在重塑產品設計重點、經營模式和臨床工作流程的結構。那些將平台策略與互通性、實證醫學和卓越服務相結合的製造商，將更有能力滿足醫院、門診中心和專科診所不斷變化的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：胃腸內視鏡設備市場：依產品類型分類

  • 配件
    • 相機
    • 導管導引線
    • 插入管
  • 內視鏡
    • 軟式內視鏡
    • 硬式內視鏡
  • 手術器械
    • 鉗子
    • 剪刀
    • 勒除器
  • 影像顯示設備
    • 相機
    • 光源
    • 監視器
    • 影像處理設備

第9章：胃腸內視鏡設備市場的可重複使用性與性別差異

  • 可重複使用的內視鏡
  • 免洗內視鏡

第10章：胃腸內視鏡設備市場：依年齡層別分類

  • 成人
  • 老年人
  • 兒童

第11章：胃腸內視鏡設備市場：依應用領域分類

  • 診斷
  • 治療

第12章：胃腸內視鏡設備市場：依最終用戶分類

  • 日間手術中心
  • 醫院
  • 專科診所

第13章：胃腸內視鏡設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：胃腸內視鏡設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：胃腸內視鏡設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國胃腸內視鏡設備市場

第17章：中國胃腸內視鏡設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Ambu A/S
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health
  • ConMed Corporation
  • Cook Medical, Inc.
  • Erbe Elektromedizin GmbH
  • Fujifilm Holdings Corporation
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • MICRO-TECH（Nanjing）Co., Ltd.
  • Olympus Corporation
  • PENTAX Medical America, Inc.
  • Richard Wolf GmbH
  • SB-KAWASUMI LABORATORIES, INC.
  • Smart Medical Systems Ltd.
  • Smith & Nephew plc
  • STERIS plc
  • Stryker Corporation
  • Teleflex Incorporated
Product Code: MRR-437E9896A4FC

The Gastrointestinal Endoscopy Devices Market was valued at USD 16.07 billion in 2025 and is projected to grow to USD 16.97 billion in 2026, with a CAGR of 5.96%, reaching USD 24.10 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 16.07 billion
Estimated Year [2026] USD 16.97 billion
Forecast Year [2032] USD 24.10 billion
CAGR (%) 5.96%

A comprehensive introduction describing clinical imperatives, technology convergence, and procurement dynamics that are redefining gastrointestinal endoscopy device priorities

The gastrointestinal endoscopy device landscape sits at the intersection of clinical necessity and rapid technological advancement, with innovation focused on improving diagnostic accuracy, therapeutic capability, and patient safety. Procedures that rely on endoscopic visualization underpin a wide range of clinical pathways, from routine screening to complex interventional therapies. Consequently, stakeholders across clinical practice, manufacturing, and health-system procurement prioritize devices that reduce procedure time, lower complication rates, and integrate seamlessly with digital healthcare workflows.

Contemporary device development emphasizes miniaturization, enhanced optics, ergonomic design, and connectivity to support image-guided interventions and remote consultation. Simultaneously, regulatory and reimbursement environments are evolving to reflect outcomes-based care and cost-containment pressures, prompting manufacturers to demonstrate value through clinical evidence and workflow efficiency. As a result, investment in research and development converges with an increased appetite among clinicians for platforms that enable both diagnostics and therapeutics under a unified technology stack.

As you consider strategic positioning, it is vital to understand how clinical trends, procurement behavior, and technology adoption interrelate. Hospitals and specialty clinics increasingly evaluate device portfolios not only on per-procedure performance but on lifecycle costs, reprocessing burdens, and compatibility with broader enterprise imaging systems. This dynamic presents opportunities for differentiated product design, value-driven service offerings, and partnerships that address the full continuum of care from outpatient screening to inpatient interventions.

An incisive analysis of how imaging leaps, infection-control priorities, and therapeutic expansion are reshaping competitive dynamics and product roadmaps

Over recent years, transformative shifts have accelerated the redefinition of competitive advantage within the gastrointestinal endoscopy ecosystem, driven by converging clinical needs and technological capability. Optical innovations and higher-resolution imaging have elevated diagnostic performance, while the integration of digital platforms and artificial intelligence is enhancing lesion detection, procedural documentation, and post-procedural analytics. These technological advances are shifting expectations, requiring device manufacturers to embed software, upgrade pathways, and interoperability considerations early in product design.

Simultaneously, the industry is responding to heightened concerns around infection control and device reprocessing. Single-use platforms have gained attention as a pragmatic option to reduce cross-contamination risk and alleviate the operational burden of complex reprocessing workflows. This has triggered a re-evaluation of capital allocation versus consumable-based models among health systems, with some providers preferring to trade equipment ownership for reliable disposables that simplify logistics and regulatory compliance.

Another significant shift is the broadening role of endoscopy beyond diagnostics toward minimally invasive therapeutics. Devices that facilitate endoluminal therapies, including advanced hemostasis, tissue resection, and endoscopic suturing, are enabling clinicians to manage conditions that previously required surgery. This transition is spurring demand for multi-functional platforms and accessory instruments that support a spectrum of interventional procedures, which in turn is reshaping training requirements, procedural guidelines, and reimbursement conversations. Collectively, these shifts are redefining product roadmaps and competitive strategies across the value chain.

A strategic examination of how new United States tariff measures in 2025 are influencing sourcing, procurement behavior, and supply chain resilience for endoscopy device stakeholders

The implementation of new tariff measures in the United States during 2025 has introduced material implications for procurement, supply chain design, and pricing strategies for endoscopy device manufacturers and buyers. Tariff-driven cost inflations on imported components and finished goods are prompting manufacturers to reassess global sourcing footprints, revisit supplier agreements, and explore nearshoring options to mitigate exposure to import duties. These adjustments require a careful evaluation of total landed cost, lead-time variability, and supplier reliability, especially for specialized components such as advanced optics, illumination systems, and precision surgical instruments.

Health systems and purchasing consortia are reacting by tightening contracting cycles and amplifying emphasis on total cost of ownership rather than unit price alone. Facility-level decision-makers are scrutinizing procurement contracts to identify opportunities for volume-based discounts, long-term service agreements, and bundled offerings that can offset incremental tariff-related costs. At the product development level, manufacturers face choices between localizing assembly, redesigning products to incorporate alternative components, or absorbing higher input costs, each with implications for margins and time-to-market.

From a strategic standpoint, businesses that proactively communicate transparent pricing adjustments and collaborate with customers on phased implementation plans tend to preserve market access more effectively. Additionally, organizations that invest in supply chain resilience-through diversified supplier networks, strategic inventory buffers, and agile manufacturing arrangements-are better positioned to stabilize delivery and maintain customer confidence amid tariff-related disruptions. Regulatory compliance and documentation become more central as customs classifications and duty treatments influence landed cost, underscoring the need for coordinated commercial, legal, and operational responses.

A nuanced segmentation perspective illuminating how product type, reusability, patient demographics, application, and care setting drive differentiated strategic choices

Segment-level dynamics reveal differentiated opportunities and constraints that inform product strategy, commercialization, and clinical adoption. Based on Product Type the market covers Accessories, Endoscopes, Operative Devices, and Visualization Equipment, with Accessories further studied across Cameras, Guide Wires, and Insertion Tubes, Endoscopes further divided into Flexible Endoscopes and Rigid Endoscopes, Operative Devices examined through Forceps, Scissors, and Snares, and Visualization Equipment broken down into Cameras, Light Sources, Monitors, and Video Processors. This product-type granularity highlights how modularity and upgradeability shape purchasing preferences, with hospitals often favoring integrated visualization systems and specialty clinics opting for optimized accessory bundles that support targeted procedures.

Based on Reusability the market differentiates between Reusable Endoscopes and Single-use Endoscopes, a segmentation that directly relates to institutional priorities around infection control, reprocessing capacity, and lifecycle economics. Based on Age Group devices and procedural pathways are considered across Adults, Geriatrics, and Pediatrics, prompting tailored design considerations such as channel size, scope flexibility, and anesthesia requirements to accommodate patient cohorts with distinct anatomical and clinical risk profiles. Based on Application the division between Diagnostics and Therapeutics signals divergent value propositions: diagnostic platforms prioritize imaging fidelity and lesion detection adjuncts, while therapeutic devices emphasize instrument channel compatibility, accessory integration, and force transmission for interventional tasks.

Based on End User the market is studied across Ambulatory Surgery Centers, Hospitals, and Specialty Clinics, each setting presenting unique procurement models, capital constraints, and throughput expectations. Ambulatory centers often prioritize rapid turnover and compact footprint solutions that optimize procedural volume, whereas hospitals require devices that support a broader case mix and cross-departmental interoperability. Specialty clinics focus on niche procedural excellence, adopting devices that deliver high-performance outcomes for focused indications. Understanding how these segments interact and where adoption curves accelerate provides the basis for tailored go-to-market strategies and product roadmaps.

A cross-regional analysis revealing how clinical demand patterns, regulatory diversity, and market infrastructure shape differentiated adoption pathways across global territories

Regional conditions govern clinical demand, regulatory pathways, and commercial models, shaping both near-term adoption patterns and longer-term strategic investments. In the Americas, healthcare delivery is characterized by a mix of high-volume academic centers, large integrated delivery networks, and proliferating outpatient facilities, which together create demand for scalable platforms that offer interoperability and strong clinical evidence to support reimbursement. Reimbursement frameworks and value-based purchasing initiatives increasingly influence procurement cycles, motivating vendors to present robust health economic data and service models that reduce total procedural cost.

In Europe, Middle East & Africa regulatory harmonization in some jurisdictions coexists with varied reimbursement regimes and infrastructure maturity across countries, requiring tailored market-entry plans. Manufacturers often prioritize regulatory approvals and local clinical partnerships to accelerate adoption, while flexible financing and training programs can overcome capacity constraints in emerging markets. The Asia-Pacific region demonstrates fast-paced adoption in urban tertiary centers paired with distinct procurement behaviors driven by public health priorities, local manufacturing ecosystems, and an expanding network of private specialty clinics. Growth in procedure volumes, investments in digital health, and rising emphasis on minimally invasive care are notable drivers.

Across regions, successful commercial strategies combine global platform consistency with localized value propositions, including language-specific software interfaces, tailored training curricula, and reimbursement support. Vendors that invest in regional clinical evidence generation and build robust service networks tend to sustain adoption momentum by addressing the specific operational and regulatory pain points that vary from one geography to another.

A decisive appraisal of company-level strengths showing why technological breadth, clinical evidence, and comprehensive service ecosystems determine market leadership

Market leadership reflects a combination of technological depth, clinical engagement, and comprehensive service offerings. Leading device-makers invest in end-to-end solutions that span optics, accessory ecosystems, and integrated visualization platforms to deliver consistent procedural experiences across care settings. Strategic partnerships between capital equipment manufacturers and consumables suppliers create defensible value propositions by lowering barriers to platform switching and offering bundled service packages that simplify budgeting and maintenance.

Companies that prioritize clinical evidence generation through multicenter studies and investigator-led research are better positioned to influence guideline development and secure favorable formulary placement within hospital systems. Equally, those that invest in scalable training and education programs build clinician familiarity and procedural confidence, accelerating adoption of advanced therapeutic features. From an operational perspective, strong aftermarket service capabilities-including rapid parts replacement, remote diagnostics, and preventive maintenance-are decisive factors in long-term customer retention.

Emerging entrants are differentiating on specific dimensions such as single-use technologies, AI-enabled diagnostic support, and purpose-built devices for niche procedures. These focused strategies can yield rapid uptake in targeted segments, particularly when supported by compelling clinical outcomes and streamlined procurement packages. For established players, sustaining competitive advantage requires continuous platform evolution, investment in interoperable software ecosystems, and proactive engagement with payer and provider stakeholders to align product value with evolving care pathways.

A set of pragmatic, high-impact recommendations guiding leaders to align product architecture, supply resilience, and clinical evidence for sustained competitive advantage

Industry leaders must act with clarity and agility to translate emerging trends into durable competitive advantage. First, invest in product modularity and interoperability so platforms can evolve through software upgrades and accessory refreshes rather than complete hardware replacement, preserving customer loyalty and lowering adoption friction. Concurrently, expand clinical evidence programs that demonstrate not only procedural efficacy but also downstream health-economic benefits; such data helps to secure placement in value-driven purchasing models and supports favorable reimbursement conversations.

Second, strengthen supply chain resilience through diversification, strategic regional partnerships, and nearshoring options for critical components. This reduces exposure to tariff shocks, logistics disruptions, and component scarcity while enabling faster response to localized demand spikes. Third, develop differentiated service models that integrate preventative maintenance, digital monitoring, and tiered support contracts to create recurring revenue streams and deepen customer relationships. Attention to training and clinician adoption is also essential; comprehensive curricula and proctoring programs accelerate safe uptake of therapeutic capabilities and broaden the addressable market for complex procedures.

Finally, pursue targeted commercial strategies by aligning offerings with the specific needs of ambulatory surgery centers, hospitals, and specialty clinics. For ambulatory centers emphasize compact, cost-effective workflows; for hospitals prioritize cross-departmental interoperability and robustness; and for specialty clinics highlight performance attributes tailored to niche indications. By aligning R&D, commercialization, and supply chain strategies to these priorities, organizations can capture sustainable growth while mitigating operational risk.

A clear exposition of the mixed-method research approach combining clinician interviews, literature synthesis, and triangulation to validate technological and commercial insights

The research methodology blends primary and secondary approaches to ensure analytical rigor and practical relevance. Primary research drew on structured interviews with clinicians, procurement leaders, clinical engineers, and senior executives across device manufacturers, conducted to surface real-world adoption drivers, operational pain points, and procurement practices. These firsthand insights were supplemented by targeted consultations with regulatory and reimbursement experts to contextualize market access barriers and facilitators across different jurisdictions.

Secondary research included systematic reviews of peer-reviewed clinical literature, professional society guidelines, patent filings, and publicly available regulatory documentation to ground technological and clinical assertions in established evidence. Trade publications, conference proceedings, and company disclosures were analyzed to capture product launches, strategic partnerships, and modality-specific innovations. Data triangulation procedures compared findings across sources to validate trends and resolve discrepancies.

Analytical techniques included thematic coding of qualitative interviews, comparative assessment of device feature sets, and scenario analysis to evaluate supply chain and regulatory contingencies. Quality assurance engaged independent subject-matter reviewers to assess methodological soundness and factual accuracy. Where uncertainties remain, the methodology explicitly documents assumptions and recommends areas for future primary study to close evidence gaps.

A conclusive synthesis highlighting why integration of clinical evidence, resilient operations, and targeted commercialization will define success in gastrointestinal endoscopy devices

In summary, the gastrointestinal endoscopy device environment is evolving under the combined influence of imaging advances, infection-control imperatives, and the expanding role of endoscopic therapeutics. These forces are reshaping product design priorities, commercial models, and the structure of clinical workflows. Manufacturers that align platform strategies with interoperability, evidence generation, and service excellence will be best positioned to meet the changing demands of hospitals, ambulatory centers, and specialty clinics.

Supply chain robustness and strategic responses to tariff developments are immediate operational priorities, while long-term competitiveness hinges on modular architectures and software-enabled value propositions. Segmentation insights underscore the need for differentiated offerings across product types, reusability profiles, patient age groups, applications, and end-user settings. Regional nuances reinforce the value of localized strategies that reflect regulatory processes, reimbursement mechanisms, and infrastructure maturity.

Overall, organizations that integrate clinical insight, operational resilience, and targeted commercialization will be well placed to convert technological opportunity into sustainable market performance, while delivering improved patient outcomes and procedural efficiencies across the continuum of gastrointestinal care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Endoscopy Devices Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Cameras
    • 8.1.2. Guide Wires
    • 8.1.3. Insertion Tubes
  • 8.2. Endoscopes
    • 8.2.1. Flexible Endoscopes
    • 8.2.2. Rigid Endoscopes
  • 8.3. Operative Devices
    • 8.3.1. Forceps
    • 8.3.2. Scissors
    • 8.3.3. Snares
  • 8.4. Visualization Equipment
    • 8.4.1. Cameras
    • 8.4.2. Light Sources
    • 8.4.3. Monitors
    • 8.4.4. Video Processors

9. Gastrointestinal Endoscopy Devices Market, by Reusability

  • 9.1. Reusable Endoscopes
  • 9.2. Single-use Endoscopes

10. Gastrointestinal Endoscopy Devices Market, by Age Group

  • 10.1. Adults
  • 10.2. Geriatrics
  • 10.3. Pediatrics

11. Gastrointestinal Endoscopy Devices Market, by Application

  • 11.1. Diagnostics
  • 11.2. Therapeutics

12. Gastrointestinal Endoscopy Devices Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Gastrointestinal Endoscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Gastrointestinal Endoscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Gastrointestinal Endoscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Gastrointestinal Endoscopy Devices Market

17. China Gastrointestinal Endoscopy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Ambu A/S
  • 18.7. Becton, Dickinson and Company
  • 18.8. Boston Scientific Corporation
  • 18.9. Cardinal Health
  • 18.10. ConMed Corporation
  • 18.11. Cook Medical, Inc.
  • 18.12. Erbe Elektromedizin GmbH
  • 18.13. Fujifilm Holdings Corporation
  • 18.14. Johnson & Johnson
  • 18.15. KARL STORZ SE & Co. KG
  • 18.16. Medtronic plc
  • 18.17. MICRO-TECH (Nanjing) Co., Ltd.
  • 18.18. Olympus Corporation
  • 18.19. PENTAX Medical America, Inc.
  • 18.20. Richard Wolf GmbH
  • 18.21. SB-KAWASUMI LABORATORIES, INC.
  • 18.22. Smart Medical Systems Ltd.
  • 18.23. Smith & Nephew plc
  • 18.24. STERIS plc
  • 18.25. Stryker Corporation
  • 18.26. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GUIDE WIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GUIDE WIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GUIDE WIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY INSERTION TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY INSERTION TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY INSERTION TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FORCEPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FORCEPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY FORCEPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SCISSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SCISSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SCISSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SNARES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SNARES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SNARES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO PROCESSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO PROCESSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO PROCESSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE-USE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE-USE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE-USE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GERIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GERIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 184. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 185. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 187. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. GCC GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 214. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 215. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 217. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. G7 GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 224. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 225. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 226. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 227. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. NATO GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY OPERATIVE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY VISUALIZATION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABILITY, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA GASTROINTESTINAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)